Welcome to FDAweb
Pay Per View
Search our 67,909 - story database FREE
Free Items
 Warning Letters
 FDA Notices
 FDA Calendar

 FDA Whistleblowers


Panel to Discuss Leadless Cardiac Pacemakers

Federal Register Notice: FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet 2/18/16, from 8 a.m. to 6 p.m. at the Hilton Washington DC North/Gaithersburg, Salons A, B, C, and D, 620 Perry Pkwy., Gaithersburg, MD. The committee will discuss and make recommendations on clinical trial, postapproval study design, and physician training requirements for leadless cardiac pacemaker device technology. It will be asked to make recommendations on the acceptability of adverse event rates in acute and chronic timeframes as well as indications for use for this device type, given availability of other technologies with different adverse event profiles. The committee will discuss required training and acceptability of observed learning curves for the new device type and necessary elements for postapproval study collection. Contact Dimitrus Culbreath, Dimitrus.Culbreath@fda.hhs.gov or (301) 796-6872. To view this notice, click here.

Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com